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ABSTRACT 
 
EPIGENETIC PROGRAMMING OF BLOOD VESSEL IDENTITY.  Aaron W. Aday, 
Lihua J. Zhu, and Nathan D. Lawson.  Program in Gene Function and Expression, UMass 
Medical School, Worcester, MA.  (Sponsored by Michael Simons, Section of 
Cardiovascular Medicine, Department of Internal Medicine, Yale University School of 
Medicine, New Haven, CT). 
Recent studies have revealed details of the signaling pathways controlling blood 
vessel development and function.  However, little is known about what controls 
endothelial cell identity in different blood vessel types.  It is important to identify 
transcriptional control elements that function in endothelial cells in order to examine their 
roles in differentiation and vascular development.  Certain histone modifications can 
serve as molecular markers for these regulatory elements.  Chromatin 
immunoprecipitation followed by deep sequencing (ChIP-Seq) allows one to identify 
DNA sequences bound by these histones, and mapping to a reference genome permits 
localization of putative enhancer and promoter regions enriched for modified histones. 
By using this technology to identify global epigenetic modifications associated with 
transcriptional activation in endothelial-expressed genes, one can locate cis-regulatory 
elements that may play essential roles in controlling cell type-specific gene expression 
and defining blood vessel identity. 
In an effort to identify cis-regulatory elements that control endothelial gene 
expression, we have performed ChIP-Seq on zebrafish embryos.  Similar to previous 
studies, promoters are enriched for modifications such as trimethylation of histone 3 at 
the fourth lysine residue (H3K4me3).  Monomethylation of histone 3 at the same position 
  
(H3K4me1) is less strongly enriched at promoter elements and often localizes up and 
downstream of predicted gene sequences or in intronic regions.  In several cases, these 
corresponding sequences are evolutionarily conserved and map to known transcription 
factor binding sites.  We have also analyzed ChIP-Seq data from endothelial cells isolated 
from zebrafish embryos by fluorescence-activated cell sorting (FACS), and this vascular 
dataset has a unique epigenetic signature compared to whole embryos.  Finally, we 
performed in vivo reporter assays and confirmed that some of the candidate enhancer 
elements identified through ChIP-Seq are able to drive gene expression.  Together, these 
resources will allow us to better understand the transcriptional regulatory networks that 
are responsible for endothelial cell heterogeneity.   
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 1 
INTRODUCTION 
Endothelial cell diversity 
 Although the entire human body depends on the vasculature for circulation of 
oxygen, nutrients, and waste products, the endothelial cells lining the vasculature possess 
distinct physiologic and morphologic features depending on their location.  For instance, 
endothelial cells in the central nervous system form tight junctions, thereby establishing 
the blood brain barrier (BBB) that protects neurons from toxic molecules in the blood.  
The endothelia of the renal glomeruli, small intestine, and endocrine tissues, however, 
have fenestrations, which allow transport of fluid and solutes.  Finally, endothelial cells 
in the liver and spleen construct gap junctions, which permit transport of large 
macromolecules and cells (1).   
Although we consider the differences in these endothelial cells in terms of their 
anatomic location and function in the mature vasculature, there is increasing evidence 
that this endothelial differentiation begins during embryogenesis.  For example, the Wnt 
signaling pathway is responsible for creation of the BBB during embryonic development 
in the mouse (2).  In this instance, the neural tube expresses the Wnt ligands Wnt7a and 
Wnt7b concomitantly with vascular invasion into the neural tube.  Furthermore, Wnt7a/b 
double mutants exhibit cerebral hemorrhage and decreased expression of BBB markers.  
Similarly, another study has shown that the endocrine-gland-derived vascular endothelial 
growth factor (EG-VEGF) can induce proliferation and development of fenestrae in 
endothelial cell cultures derived from endocrine tissues (3).  Of note, this molecule has 
little effect on endothelial cells harvested from other tissues, and EG-VEGF mRNA is 
restricted to the human ovaries, testes, adrenal glands, and placenta.  These results 
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suggest a tissue-specific response to EG-VEGF similar to that of Wnt7a/b in the mouse 
neural tube. 
In addition to molecular and morphological differences in organ-specific vascular 
systems, further evidence supports a role for endothelial differentiation in the early 
development of a somatic vascular network in vertebrates.  Endothelial cells in the dorsal 
aorta of the zebrafish must differentiate into cells with distinct morphologies to form 
angiogenic sprouts (4; 5).  Furthermore, tip cells at the leading edge of these new vessels 
preferentially express flt4, which is notably absent from the stalk cells making up the 
body of the sprouts as well as from the dorsal aorta, from which these tip cells originated 
(5).  Disruption of the pathways responsible for this differentiation leads to severe 
vascular defects (5-7).  Similarly, populations of endothelial precursors in the anterior 
lateral mesoderm that ultimately give rise to the anterior lateral dorsal aortae express both 
kdrl and cxcr4, while those in the posterior lateral mesoderm giving rise to the posterior 
lateral dorsal aortae express only kdrl (8).  These different cell populations also exhibit 
distinct migratory patterns as they coalesce to form the patent vasculature.  Given this 
body of evidence, endothelial cell differentiation plays a critical role in vertebrate 
vascular development. 
Transcriptional control of endothelial cell identity 
Although we now have more insight into the degree of endothelial diversity, we 
lack a complete understanding of the processes controlling development of this 
heterogeneous cell population.  One critical research focus is the cell fate decision to 
transition from a common endothelial precursor into a committed arterial or venous fate.  
In vertebrates, this commitment occurs in embryogenesis prior to the onset of circulation 
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(9).  Numerous studies have identified roles for components of the vascular endothelial 
growth factor-A (Vegf-A) and Notch signaling pathways in arterial endothelial 
differentiation (10-15).  In addition, several transcription factors related to these 
pathways play key roles in arterial specification.  Hey2 is a helix-loop-helix 
transcriptional repressor necessary for proper dorsal aorta development in the zebrafish 
(16; 17).  Initially expressed in the lateral posterior mesoderm, it is later restricted to the 
dorsal aorta (16).  Knockdown of hey2 results in degradation of the axial arterial 
vasculature and both expansion of the venous vasculature and an increase in expression 
of ephb4, a venous marker (17).  Notch signaling can activate hey2, although it appears 
this may be mediated by other factors and can also occur independently of Notch 
signaling (18).  Similarly, the forkhead transcription factors Foxc1 and Foxc2 are 
important for specifying arterial fate (19; 20).  In mouse, foxc1/2 mutants exhibit a shunt 
connecting the dorsal aorta and cardinal vein, and these mutants also lack expression of 
the arterial markers dll4, hey2, and ephB2 (19).  Further biochemical studies show that 
Foxc1 and Foxc2 directly interact with Notch downstream activating elements to induce 
hey2 expression (20).  These analyses also indicate that VEGF-activated 
phosphoinositide 3-kinase (PI3K) modulates Foxc1/2 activation of dll4 and hey2.   
Several groups have examined the sex determining region Y-related high mobility 
group (SOX) transcription factors and their roles in zebrafish vascular development (21; 
22).  Sox7 is primarily expressed in the dorsal aorta, while sox18 is expressed throughout 
the vasculature (21).  Whereas sox7 expression is dependent on Scl, Vegf signaling and 
sonic hedgehog signaling, sox18 is unaffected by loss of Scl or inhibition of either Vegf 
or sonic hedgehog signaling (21; 22).  In addition, double knockdown of sox7 and sox18 
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results in loss of trunk circulation and the formation of arteriovenous shunts (21; 22).  
More recent evidence suggests a role for sox18 in regulating lymphatic endothelial cell 
differentiation in mouse (23). 
Another important transcription factor for vascular development is the Ets 
transcription factor etsrp.  Morpholino knockdown of etsrp in zebrafish results in the 
absence of angioblast differentiation and migration and a complete lack of circulation 
(24).  Interestingly, Foxc2 and Etv2 (the mouse orthologue of Etsrp) can bind an 
endothelial-specific motif present in many endothelial enhancers (25).  This study also 
shows that combinatorial expression of these factors induces ectopic vascular gene 
expression in Xenopus, and knockdown of both factors in the zebrafish leads to aberrant 
vascular development.  Despite our steadily increasing knowledge of roles for these and 
other transcription factors in vascular development, there still remain numerous gaps in 
our understanding of this regulatory network and how it may contribute to endothelial 
heterogeneity.   
Cis-regulatory elements and their roles in development and human disease 
As the Foxc2/Etv2 study illustrates (25), the cis-regulatory elements to which 
transcription factors bind also play important yet poorly understood roles in cell lineage 
commitment.  Cis-elements are a group of non-coding DNA regions that include 
promoters, enhancers, and insulators.  Proximal promoter elements are genomic regions 
immediately upstream of genes that serve as sites for RNA polymerase II binding and 
recruitment of other transcription factors necessary for the initiation of transcription.  
Enhancers, however, can lie many kilobases up or downstream of their target genes and 
may even be present within the genes themselves.  When bound by transcription factors, 
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enhancers may reorient chromatin architecture through looping to facilitate interaction 
with the transcriptional machinery occupying the promoter (26). This interaction is often 
tissue-specific depending on the binding motifs present in the enhancer.  In arthropods, a 
conserved enhancer in the tinman gene complex drives expression of different 
transcriptional repressors in a species-dependent manner, and a chromosomal inversion, 
which redirects action of the enhancer, determines the specific expression pattern (27).  
Evidence from Drosophila also illustrates the role of promoter tethering elements and 
other proximal-promoter sequences to ensure specificity of such long-range interactions 
(28).  It is possible that enhancers in close proximity to promoters may be able to 
function via direct interaction, thereby forgoing chromatin looping (26).  Furthermore, 
proteins binding to enhancers may also interact with modified histones to facilitate 
transcription factor recruitment (26).   
In contrast, insulators play more restrictive roles within the genome to ensure 
correct interactions between genomic regions.  Enhancer-blocking insulators inhibit 
enhancer/promoter interaction through protein recruitment, and barrier insulators help 
prevent heterochromatin formation and subsequent gene silencing from occurring in 
critical regions (29).  Interestingly, in Drosophila, the Homie insulator region blocks 
short-range promoter/enhancer interactions but can facilitate long-range interactions (30). 
Several studies have illustrated the important roles of cis-elements in vascular 
development.  In the zebrafish, a 5kb region upstream of the transcription start site (TSS) 
of kdrl (VEGFR-2) is both necessary and sufficient to drive expression of kdrl (31).  This 
sequence contains binding sites for Ets factors as well as FoxH1, which functions as a 
repressor of vascular development.  Kdrl upstream sequences in both mouse and human 
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also contain some of these binding sites, suggesting evolutionary conservation of these 
cis-elements.  Similarly, the FOX:ETS motif, which synergistically binds both Foxc2 and 
Etv2, is present in many endothelial-specific enhancers, and mutations in these motifs 
eliminate their corresponding endothelial expression (25). 
Previously, there has been little focus on the roles of non-coding genomic 
elements in human disease.  However, it is increasingly clear that disease states cannot be 
completely explained by aberrations in coding sequences alone.  In a subset of patients 
with α- or β-thalassemia, the disease results from deletions or rearrangements causing 
repositioning of enhancers required for globin gene expression (32).  Similarly, single 
nucleotide variations in the ZRS enhancer are associated with human preaxial 
polydactyly (33).  This enhancer normally drives expression of Shh even though it lies in 
the intron of a different gene approximately one megabase away from Shh.  Deletion of 
this enhancer results in loss of Shh expression as well as severe limb truncation in the 
mouse (34).  Finally, some individuals possess a common variant in an enhancer located 
in the first intron of the RET proto-oncogene; this variant confers a greater risk of 
developing Hirschprung’s disease than the risk conferred by mutations in coding 
sequences (35). 
Given the role of cis-elements in both normal development and human disease, 
there is a definite need for more research in this area.  However, one problem facing 
researchers is the difficulty in identifying functionally active cis-elements with significant 
roles in any given process.  Although some studies have used known transcription factor 
binding motifs to identify enhancers, not all predicted motifs actually bind these factors 
(26).  Furthermore, occupancy studies have shown that some transcription factors bind 
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sequences lacking their predicted binding motifs (25).  In many cases, this approach is 
also limiting because the relevant DNA-binding protein is unknown.   
Computational approaches to identifying cis-elements 
To address these problems, some studies have utilized alternative approaches.  
One study combined transcription factor occupancy data with known expression patterns 
of cis-regulatory elements at different timepoints in Drosophila (36).  They trained an 
algorithm to predict spatiotemporal expression based on this dataset, and this algorithm 
was able to correctly predict expression patterns with >70% accuracy.  Another study in 
zebrafish relied on the notion that highly conserved non-coding elements (NCEs) may 
represent candidate enhancers because evolutionary pressure to ensure their persistence 
over millions of years in multiple species suggests functional significance even though 
they do not encode gene products (37).  In this report, the researchers chose 101 
candidate enhancers based on their proximity to genes with known tissue-specific 
expression patterns in the brain.  These enhancers were located up to 500 kilobases up or 
downstream of these genes, and they chose enhancers with a minimum of 60% shared 
identity and 100 base pairs of conservation between humans and zebrafish.  Based on this 
approach, they were highly successful in predicting enhancers with tissue specificity, and 
they confirmed in vivo function of 76/101 of the predicted enhancers.  A similar study in 
zebrafish examined a 200kb region up and downstream of fgf8a in the zebrafish genome 
(38).  They identified 18 NCEs, including some within the nearby genes slc2a15a and 
fbxw4, and tested these using an in vivo reporter assay.  Of their 18 candidates, 14 were 
able to drive gene expression, often in a pattern consistent with that of fgf8a.  Finally, 
other research has used known cis-regulatory elements with common gene expression 
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patterns to train algorithms to predict other cis-elements that will yield similar expression 
patterns (39).  Using this method, researchers were able to predict and validate in vivo 
enhancers in both Drosophila and mouse.   
Despite advances in predicting cis-regulatory elements, these approaches have 
several limitations.  Without knowledge of a relevant DNA-binding protein, it still 
remains difficult to predict spatiotemporal expression of enhancers.  Although some cis-
elements are evolutionarily conserved in different genomes, they may have moved 
relative to their target genes, further complicating efforts to determine their significance.  
Also, DNA conservation itself presents several problems.  Highly conserved regions may 
function as insulators, not enhancers, or may encode non-coding RNAs (32).  
Furthermore, cross-species conservation can be a poor predictor of functional relevance.  
One study deleted four highly conserved regions in the mouse genome that were known 
to function as tissue-specific enhancers (40).  Surprisingly, researchers observed no 
phenotypes in these mouse mutants, although deletion of their corresponding genes 
yielded a phenotype in all cases.  Thus, it is important to utilize more reliable methods for 
predicting cis-regulatory elements. 
Epigenetic modifications and cis-elements 
Recently, much attention has focused on using epigenetic modifications as 
markers for cis-regulatory elements and other regions of the genome.  One such marker is 
modified histones.  Histones are proteins around which DNA wraps to form chromatin.  
In eukaryotes, the octameric histone core consists primarily of two copies each of 
histones 2A, 2B, 3, and 4; an additional histone, H1, resides outside the core.  Typically, 
146 base pairs of DNA bound to the octameric core comprise a nucleosome.  By forming 
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chromatin, cells are able to compact DNA within the nucleus.  Additionally, cells can 
restrict access of transcription factors to their respective binding sites through chromatin 
folding and unfolding, and this interplay between euchromatin and heterochromatin is a 
major mechanism of gene regulation (41; 42).  Following translation, cells can 
enzymatically modify the N-termini of histones through phosphorylation, acetylation, 
methylation, and ubiquitylation, all of which affect chromatin conformation and, 
therefore, protein access to DNA (43).  Since researchers are now able to reliably detect 
these modifications and map them to their corresponding genomic regions, epigenetic 
studies have emerged as powerful tools for genome-wide prediction of genomic elements. 
Next-generation deep sequencing 
In order to characterize the distribution of histone modifications, chromatin 
immunoprecipitation (ChIP) followed by either microarray analysis (ChIP-chip) or next 
generation sequencing (ChIP-Seq) have become the primary technologies for such 
studies.  These experiments generally entail crosslinking of DNA to histones and other 
DNA-binding proteins by formaldehyde or other reagents.  The chromatin is broken into 
small fragments of several hundred base pairs either through sonication or micrococcal 
nuclease digestion.  Proteins and their corresponding DNA can be isolated following 
incubation with antibodies specific to the histone modification of interest.  The 
DNA/protein bond is subsequently dissolved, and only DNA sequence previously 
associated with the modified histone remains.   
Several options exist for detection of the immunoprecipitated DNA.  Perhaps the 
most powerful of these options is next generation sequencing.  Of the new sequencing 
technologies, one of the most popular is Illumina’s Genome Analyzer (formerly Solexa).  
 10 
To prepare samples for Illumina sequencing, blunt ends are created on the DNA 
fragments through enzymatic polymerase or exonuclease activity.  Short, proprietary 
Illumina oligonucleotide adapters are ligated to the fragments, and the samples undergo 
PCR amplification.  Quality control checks such as shotgun cloning and sequencing of 
fragments or PCR analysis of the final product ensure that the sample preparation was 
successful.  At this point, the samples are ready for deep sequencing.  The single-stranded 
samples are adhered to a flow cell surface and amplified using universal primers to create 
unique clusters of each fragment (44).  The sequencing occurs through single-base pair 
reversible terminator technology.  Each base pair contains a removable fluorophore.  
Although only one base pair is incorporated into each strand at a time, all four reversible 
terminators can be used simultaneously.  After each incorporation step, lasers excite the 
fluorophores, and these images are recorded.  Next, the fluorophores are chemically 
removed, and 3’ hydroxyl groups are added to allow incorporation of the next base pair.  
Rather than sequence the entire fragment, the reaction continues for ~20-70 base pairs, 
depending on the machine (45; 46).  In addition, the newer Genome Analyzers can 
sequence from both ends of each fragment cluster, thus providing more information for 
subsequent genome mapping.  Each machine can sequence up to eight samples, or lanes, 
per run, and the newer machines can yield 4-5Gb of sequence (100-400 million sequence 
tags) with <1% base-calling error (46; 47). 
Following the sequencing reactions, the fluorescent signals are quantified, and a 
base-calling algorithm determines the sequence.  Subsequently, the sequences must be 
aligned to a reference genome, and several programs, such as ELAND, MAQ, and 
Bowtie, exist for such a purpose.  These programs differ primarily in their cut-offs for 
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acceptable base calling quality and their methods of handling fragments that map to 
multiple regions (48).  After mapping, there are several ways of handling this massive 
amount of sequence data.  The sequence tags can be uploaded to the UCSC genome 
browser, which can visually display the distribution of sequences and, therefore, 
enrichment for the histone modification of interest around TSSs, enhancers, introns, and 
other elements.  In such cases, it is often useful to first normalize the sequence data to an 
“input” sample, which represents sheared chromatin that was treated with preimmune 
serum or that did not undergo immunoprecipitation (49).  Alternatively, one can create a 
tab-delimited file in which regions of significant enrichment for each histone 
modification are sorted by genomic coordinates or number of uniquely mapping sequence 
tags in that region. 
The newer sequencing technologies such as Illumina’s offer several key benefits 
over microarray-based sequencing. Because it is based on oligonucleotide hybridization, 
ChIP-chip is subject to factors such as probe GC content and length.  As a result, ChIP-
chip is more prone to hybridization artifacts that can affect sequence mapping (47; 50).  
Additionally, microarrays require a large number of probes to ensure high-resolution 
mapping, and this greatly increases the cost of experiments needing such detail.  This is 
avoided in ChIP-Seq, which provides single base pair resolution with every run.  Finally, 
in addition to being less costly, ChIP-Seq requires less starting DNA, which is crucial for 
experiments using small cell populations (45).   
ChIP-Seq as a tool for identifying epigenetic modifications 
Given the ability of ChIP-Seq to identify protein-bound regions of DNA with 
single-base resolution, many researchers have begun mapping histone modifications 
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throughout the genome.  One study in particular used the Solexa 1G Genome Analyzer to 
localize numerous modified histones in CD4+ T cells following micrococcal nuclease 
digestion of chromatin (51).  This study found a strong enrichment of tri-methylated 
lysine 4 on the H3 subunit (H3K4me3) at the TSS, and this enrichment corresponded 
strongly to gene expression.  Interestingly, there was a distinct paucity of this enrichment 
from -200 to +50 of active genes, which they attributed to a loss of nucleosome 
architecture in order to accommodate the transcriptional machinery.  Similar reports 
found strong enrichment of H3K4me3 at the TSS in Xenopus as well as at the TSS in 
multiple different human cell lines (52; 53).  Further evidence suggests that H3K4me3 
modifications can persist beyond gene activation, thereby serving as a marker of past 
transcription and somehow modulating future gene regulation (54).  Other research 
suggests that H3K4me3 combined with an additional modification conveys a signal 
different from a single modification alone, and this bivalent modification can interact 
with other modified histones and transcription factors to regulate gene expression (55). 
In Barski et al. (51), mono-methylation of the lysine residue (H3K4me1) was also 
associated with the TSSs of active genes, although the enrichment was less than that of 
H3K4me3.  Also, H3K4me1 enrichment extended well beyond 2kb up and downstream 
of the TSS, while H3K4me3 enrichment was largely confined within 1kb of the TSS.  In 
contrast, the modification H3K27me3 was strongly enriched in silent regions of the 
genome, and its distribution did not vary surrounding the TSS.  This finding is consistent 
with other studies using CD4+ T cells (56; 57) 
The group also examined several known enhancers and found strong enrichment 
of both H3K4me1 and H3K4me3 (51).  Furthermore, they examined ~3500 sites of 
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DNase hypersensitivity, which is used as a marker for open chromatin available for 
protein interactions.  At these sites, they discovered H3K4me1 enrichment over a broad 
region and H3K4me3 enrichment in a more narrowly delineated distribution, further 
suggesting these two marks can indicate enhancer elements.  Interestingly, they also 
examined H3K4me1 and H3K4me3 enrichment at binding sites for CTCF, a known 
insulator-binding protein.  Both modifications were enriched in these regions, although 
H3K4me3 enrichment was slightly stronger. 
One limitation of this study is the small number of enhancers examined (51).  
Additionally, other studies have found conflicting evidence regarding H3K4me3’s 
association with cis-regulatory elements.  Using a different approach in HeLa cells, one 
group found H3K4me1 association with 96% of binding sites for the transcription factor 
STAT1 (58).  Of note, these sites were downstream of the TSS.  Another study used 
ChIP-chip to examine binding of P300, an enhancer-binding protein, in HeLa cells and 
found that the binding sites were primarily associated with H3K4me1, not H3K4me3 
(59).  Finally, a ChIP-chip study in human cell lines found enrichment of H3K4me1 at 
predicted enhancers, although the degree of enrichment varied among cell lines (53).  
Therefore, H3K4me1 may be a more reliable marker of cis-regulatory elements. 
Given the association between histone modifications and cis-regulatory elements, 
it may be possible to use ChIP-Seq as a means to globally identify candidate elements 
based solely on epigenetic modifications.  One group attempted a similar study using the 
p300 enhancer-binding protein instead of histone modifications (60).  In this study, ChIP-
Seq was used to map p300 binding in mouse forebrain, midbrain, and limb tissue.  
Approximately 10-21% of the identified peaks of enriched p300 binding were highly 
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conserved, and most of them were >10kb from the TSS.  Although most of the peaks 
from each tissue were unique, there was some overlap.  From this dataset, they identified 
86 candidate enhancer elements and cloned them into LacZ reporter constructs.  Of these 
candidates, 87-88% functioned as enhancers in their respective tissues.  This is compared 
to a rate of ~50% when relying upon ultraconservation as a means of predicting candidate 
enhancers (61).  In addition, candidates were 5-16 times more likely to drive reporter 
expression in their respective tissue of origin than if the enhancers were predicted based 
on computational means alone (60). 
As this study demonstrates (60), ChIP-Seq allows one to globally identify 
enhancer elements with high accuracy and tissue specificity.  However, relying upon 
enhancer-binding proteins has several disadvantages.  Whereas histone modifications do 
not bias toward one class of enhancer, ChIP-Seq for a specific protein necessarily limits 
the scope of the experiment.  Indeed, there may be critical enhancer elements for which 
the corresponding binding proteins are unknown.  Also, in some cases, the protein may 
not be conserved to such a degree that available antibodies function in different species.  
Finally, focusing on enhancer-binding proteins prevents one from discovering other 
NCEs such as insulators or miRNAs.  Therefore, ChIP-Seq studies using histone 
modifications are ideally suited for identifying enhancers and other cis-regulatory 
elements.   
Zebrafish as a model system for vascular development 
Since ChIP-Seq has already shown to be useful in identifying tissue-specific cis-
regulatory elements, it is an ideal technique for identifying such elements in the 
vasculature (60).  The zebrafish, Danio rerio, offers several key benefits in studying 
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vascular development.  Zebrafish embryos develop external to the mother, which permits 
easy collection and visualization.  At 24 hours post fertilization (hpf), the heart begins to 
beat, and the cardiovascular system is largely developed by 72hpf (62).  Also, embryos 
possess transparent skin, which permits whole-mount in situ hybridization as well as 
direct visualization of the heart, vasculature, and other organs.  Transgenic fish lines have 
been developed which allow visualization of the vasculature using GFP under the control 
of an endothelial-specific enhancer/promoter (63).  Technology already exists for rapidly 
cloning candidate enhancers and confirming their function in vivo (37; 64).  Given these 
advantages, the zebrafish constitutes an excellent model system to investigate the cis-
regulatory network controlling vascular development. 
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HYPOTHESIS/AIMS 
 By using histone modifications as markers, we identified cis-regulatory elements 
that function to induce gene expression within the zebrafish vasculature.   
1.  Create an epigenetic map of histone modifications in the zebrafish embryo.  
Using ChIP-Seq, we mapped the distribution of various modified histones throughout the 
genome.  We determined the correlation of these modifications to TSSs, NCEs, and 
known transcription factor binding sites.  Also, we developed this epigenetic map for 
whole embryos as well as a purified population of zebrafish endothelial cells. 
2.  Determine epigenetic signatures for common transcription factor binding sites.  
We examined datasets composed of genes in common signaling pathways.  Within these 
sets, we looked at regions of enrichment for specific modified histones and determined 
overrepresented transcription binding sites.  By doing so, we demonstrated that binding 
sites for some critical transcription factors are significantly associated with specific 
modified histones, further demonstrating the utility of such epigenetic maps in predicting 
the functional relevance of non-coding genomic regions. 
3.  Identify cis-regulatory elements that function in the zebrafish vasculature.  Using 
our epigenetic map, we identified candidate enhancer elements based on the degree of 
modified histone enrichment, evolutionary conservation, and proximity to genes with 
vascular expression.  We then cloned these candidates into a reporter construct and 
validated their function in vivo, thereby demonstrating the utility of ChIP-Seq in globally 
identifying cis-regulatory elements. 
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METHODS 
Except where noted, all experiments were performed by Aaron Aday. 
Zebrafish husbandry 
Fish lines were raised and maintained by Animal Medicine at UMass Medical 
School as previously described (65).  Wild type (WT) lines were TL and CF.  The 
Tg(fli1:egfp)y1 fish line has previously been developed (63).  
Chromatin immunoprecipitation 
 For ChIP on whole embryos (Fig. 1A), I used 200 WT embryos staged at 24hpf 
according to accepted standards (62).  Embryos were dechorionated with a 3-minute 
pronase incubation and washed with calcium-free Ringers (0.5M NaCl, 0.3M KCl, 0.5M 
HEPES, pH 7.2).  I then deyolked the embryos by passing them repeating through a P200 
pipet tip, washed with calcium-free Ringers, and dissociated the embryos for one hour at 
28°C in a 1X trypsin solution.  This reaction was halted with collection medium 
(Leibovitz L-15, 0.3mM glutamine, 0.8mM CaCl2, Pen 50U/mL/Strp 0.05mg/mL, and 
11% fetal calf serum).  I washed the cells twice with collection medium, centrifuging 
between each wash.  Next, I created DNA/protein crosslinks with a 1% formaldehyde 
solution in 1X PBS for 10 minutes at room temperature.  After adding 2M glycine, I 
centrifuged the samples and resuspended the pellets in SDS lysis buffer (50mM Tris-HCl, 
pH 8.1, 10mM EDTA, 1% SDS).  In order to shear the chromatin, I sonicated each 
sample using a Microsonicator (Cole and Palmer Instruments) with a 6mm micro tip.  
Each sample underwent sonication for a minimum of five minutes at 30% intensity, and 
samples were kept in ice water during the sonication.  After five minutes, I analyzed 1% 
of the sample using gel electrophoresis on a 1% TAE agarose gel to ensure the 
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distribution of chromatin fragments was between 200-1,000bp.  If the range significantly 
exceeded 1,000bp, I performed additional sonication in intervals of 1 minute, again 
analyzing 1% of the sample after each additional round.  I then centrifuged each sample 
and diluted the supernatant 1:10 in IP buffer (16.7mM Tris-HCl PH 8.1, 1.2mM EDTA, 
1.1% Triton-X-100, 0.01% SDS, 167mM NaCl).  1% of this solution was set aside and 
stored at -20°C to serve as an input control for each corresponding immunoprecipitation.  
Next, each sample was incubated in an agarose bead solution.  This “pre-clearing” helps 
remove any elements from the sample that may bind non-specifically to the agarose 
beads themselves (58).  To accomplish this, I centrifuged ChIP-grade protein A agarose 
beads (Sigma), removed the supernatant, and washed the beads in IP buffer.  After again 
centrifuging, I added block solution to the beads.  This consisted of sheared salmon 
sperm (Invitrogen) at 20µg per 50µL of final volume, BSA at 1mg/mL, and IP buffer 
until the final volume was equal to that of the initial unwashed bead slurry.  I added 80µL 
of this bead mixture to each sample and incubated 30 minutes at 4°C.  After centrifuging, 
I collected the supernatant and split it evenly into microcentrifuge tubes.  For every 
sample, half of this supernatant was treated with antibody and half served as a negative 
control.  I used 8µg of antibody per sample, and our antibodies included anti-H3K4me1 
(ChIP-grade, Abcam) and anti-H3K4me3 (ChIP-grade, Abcam).  All samples were 
incubated overnight at 4°C.  Both antibody-treated and untreated samples were then 
incubated with protein A agarose beads.  These were washed and combined with 
blocking solution as before, but only 50µL was added to each sample.  After a one hour 
incubation at 4°C, I centrifuged samples and washed with ChIP wash buffers A (20mM 
Tris-HCl pH 8.1, 2mM EDTA, 1% Triton-X-100, 0.1% SDS, 150mM NaCl), B (20mM 
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Tris-HCl pH 8.1, 2mM EDTA, 1% Triton-X-100, 0.1% SDS, 500mM NaCl), C (10mM 
Tris-HCl pH 8.1, 1mM EDTA, 1% NP-40, 1% sodium deoxycholate, 0.25M LiCl), and 
twice in TE solution (10mM Tris-HCl, 1mM EDTA).  Next, I added 200µL elution buffer 
(0.1M NaHCO3 and 1% SDS) to all samples.  I also added 180µL of elution buffer to 
input samples for a final volume of 200µL.  These were vortexed briefly and then 
incubated 15 minutes at room temperature.  At this point, I set aside the input samples 
and centrifuged the remaining samples that contained agarose beads twice, collecting the 
supernatant each time.  This ensured no agarose beads remained in our samples.  Finally, 
I added 20µL of 5M NaCl to all samples (including input) and incubated overnight at 
65°C to reverse the formaldehyde crosslinks.  After this step, I purified all samples using 
a PCR purification kit (Qiagen) and eluted with 50µL EB.  All ChIPs were performed in 
duplicate.   
  
In order to determine the minimum number of cells needed for successful ChIP, I  
prepared WT embryos as described above.  I counted cells using a hemacytometer and 
proceeded to ChIP experiments with 1x105, 5x105, and 1x106 cells using the same 
protocol as for whole embryos. 
formaldehyde
sonication AB
protein agarose 
beads
NaCl
A
Sequence with Illumina 1G
Map reads to zebrafish 
genome
Normalize regions of 
enrichment to input samplesB  
Figure 1: ChIP-Seq to identify epigenetic modifications in zebrafish.  A – Schematic of ChIP to isolate DNA 
sequences associated with different modified histones.  B – Illumina pipeline for deep sequencing following ChIP.  
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 For ChIP on endothelial cell populations, I began with 1,000-1,500 Tg(fli1:egfp)y1 
embryos.  These were dechorionated, deyolked, and trypsinized as described above.  
Fluorescence-activated cell sorting (FACS) was performed by the UMass Medical School 
Flow Cytometry Core Lab.  I used ~500,000 GFP+ cells, which consisted almost entirely 
of endothelial cells, as well as ~500,000 GFP- cells as a negative control for each 
immunoprecipitation.  Samples only required 4 minutes of sonication.  Also, for these 
experiments, I only used the anti-H3K4me1 antibody, and I added 4µg instead of 8µg.  
The protocol is otherwise the same as for whole embryos.  All experiments were 
performed in duplicate. 
Confirmation of successful ChIP 
 In order to confirm the success of each ChIP experiment, I performed several 
quality checks.  For whole embryos, I first measured each sample’s concentration using a 
Nanodrop 2000 (Thermo Scientific).  Next, I performed PCR amplification on all 
samples using primers specific for ~100bp regions upstream of the TSS for several 
housekeeping and vascular genes.  These genes included gapdh, ef1α, aqp8, and fli1b 
(Table 1).  Primers were designed using Primer3Plus (http://www.bioinformatics.nl/cgi-
bin/primer3plus/primer3plus.cgi) and synthesized by Invitrogen.  For the PCR reactions, 
I used Platinum Taq polymerase (Invitrogen).  I analyzed samples by gel electrophoresis 
on 2.5% TAE low-res ultra agarose gels. 
 The yield from ChIPs performed on small populations of embryonic cells as well 
as our purified endothelial cell populations was too low for detection by Nanodrop.  
Instead, for these samples, I performed quantitative PCR using Applied Biosystems 
instruments and primers specific to promoter regions of fli1b, aqp8, and ef1α (Table 1).  
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Each reaction was performed in triplicate in a 96-well plate using Power SYBR green 
PCR Master Mix (Applied Biosystems) according to described methods (66).  I 
quantified these promoter sequences for antibody, input, and negative control samples.  
After detection, I 
averaged the 
threshold cycles 
(Ct) for each 
sample.  I next determined fold enrichment of antibody sample relative to negative 
control with normalization to the average Ct for input samples.  This was accomplished 
using the following calculation:  
2[(Average input Ct-Average antibody Ct)-(Average input Ct- Average negative control Ct)].   
Genome Analyzer sample preparation 
 For whole embryos, I began with 80ng of ChIP-isolated DNA for both antibody 
and input samples.  First, I created blunt ends on all fragment using an END-IT DNA 
Repair Kit (Epicentre).  This reaction proceeded for 45 minutes at room temperature, 
after which samples were purified using a Gel Extraction Kit (Qiagen) and eluted with 
EB.  Next, I added a single adenosine to the 3’ ends using 50 units of Klenow Exo-minus 
(Epicentre).  After one hour at room temperature, I again purified the samples using a Gel 
Extraction Kit.  At this point, I concentrated the samples using a speed vacuum.  Next, I 
ligated Genome Analyzer adapters (Illumina, P-GATCGGAAGAGCTCGTATGCCGTC 
TTCTGCTTG and ACACTCTTTCCCTACACGACGCTCTTCCGATCT) to the ends of 
our sample fragments.  For this, I used a Fast Link Kit (Epicentre) along with the adapter 
mix at 0.3µM.  After a two-hour incubation at room temperature, I added additional 
Gene Forward Primer (5’3’) Reverse Primer (5’3’) 
fli1b CTTGTTATGCGCTTACCTGGTC GTTACATGCTGTGTATGCCATTG 
aqp8 CTCACTGTGACGGCAAATATC TTTAAGCAGTCGGCTACAGG 
gapdh AAATTACTTCTGCCTGGTTTCC GGCCATGATTCTGTAAGCAC 
ef1α AGGCGGGGAGATTTTCAG TTTATATGCGGGAGGAGGAC 
Table 1: Primers for ChIP Validation and qPCR 
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ligase, buffer, and ATP and incubated the samples overnight at 16°C.  I purified our 
samples with a Gel Extraction Kit and began PCR amplification.  Initially, I performed 
test PCRs with various numbers of amplification steps to determine the correct number of 
steps that would provide us enough working material without increasing our risk of PCR-
induced artifacts (67).  Because of the high cost of Illumina’s proprietary primers, I 
designed my own primers specific to the Illumina adapters (F – AATGATACGGCGACC 
ACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT and R – CAAGC 
AGAAGACGGCATACGAGCTCTTCCGATCT).  For the PCR, I used PfuUltraTM II 
Fusion HS DNA polymerase (Stratagene) and 2µL of my adapter-ligated samples.  I 
analyzed 10% of our sample following 15, 18, and 20 rounds of amplification on 2% 
TAE low-res ultra agarose.  After deciding on an appropriate number of amplification 
steps, I repeated this PCR using Illumina’s Genome Analyzer primers (primers 1.1 and 
2.1, final concentration of 2.5µM).   
 Since I could not reliably quantify samples from our cell sorting experiments, I 
used 100% of our ChIP-isolated DNA (~30µL) instead of specifying 80ng for Genome 
Analyzer sample preparation.  Also, for the adapter ligation step, the final concentration 
of adapters was 1.5µM.  Otherwise, the preparation steps were identical. 
Size selection and quality check 
 After PCR amplification, I used gel electrophoresis to analyze our samples on 2% 
TAE low-res ultra agarose.  Using a clean razor blade, I excised the gel containing bands 
between 200-400bp, carefully avoiding smaller bands that contained self-ligated adapters 
(46).  I separated this agarose equally into two microcentrifuge tubes and performed gel 
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extraction using a Qiagen Gel Extraction Kit.  I eluted with 30µL EB, pooled identical 
samples, and quantified using the Nanodrop. 
 In order to confirm success of our sample preparation prior to sequencing, I 
performed PCR using Platinum Taq (Invitrogen) and primers for promoter regions of 
aqp8, fli1b, and gapdh (Table 1).  Afterward, I performed gel electrophoresis on 2.5% 
TAE low-res ultra agarose gels.  Since I had already performed PCR amplification and 
gel extraction to ensure all remaining samples possessed properly ligated adapters, 
samples that also yielded bands from this PCR test represented successfully prepared 
samples.  
Sequencing 
 All deep sequencing was performed on an Illumina 1G Genome Analyzer (Fig. 
1B) operated by the UMass CFAR Deep Sequencing Core.  Sequencing was performed 
using 36bp single-end reads.  For whole embryos at 24hpf, we sequenced 6 total lanes of 
the H3K4me1, H3K4me3, and input samples as well as 4 lanes of each replicate.  For the 
endothelial cell ChIP-Seq experiments, we sequenced 4 total lanes for the H3K4me1 and 
input GFP+ samples as well as 1 lane for each replicate. 
Base calling and mapping 
 We used an existing pipeline consisting of the Firecrest and Bustard applications 
for base calling and generating sequence tag files.  This analysis was performed by the 
UMass CFAR Deep Sequencing Core.   
 Next, we mapped the sequence tags to the zebrafish genome (Zv7) using BLAT.  
This software generated genomic coordinates for all tags (68).  Only tags with unique 
genomic coordinates and less than 2bp of mismatch were included in subsequent 
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analyses.  This analysis was performed by Dr. Julie Zhu, a bioinformatics programmer at 
UMass Medical School. 
Computational analysis of putative cis-regulatory elements 
To determine regions of significant enrichment for specific histone modifications, 
termed “peaks,” we used the MACS algorithm, which allowed us to calculate significant 
differences in modified histone enrichment between our ChIP and input samples (69).  
The p-value cutoff for a significant peak was 1e-5.  After these analyses, the genomic 
coordinates of all significant peaks were formatted into tab-delimited files, and I also 
uploaded this data to the UCSC genome browser (http://genome.ucsc.edu/) for visual 
analysis.  The MACS analysis was performed by Dr. Julie Zhu. 
We also analyzed our dataset for overrepresentation of transcription factor 
binding sites.  To do this, we first used Clover, which is an algorithm that scans DNA 
sequences for over- and under-represented motifs of known transcription factor binding 
sites (71).  We searched for NCEs as well as regions of H3K4me1 and H3K4me3 
enrichment within sequences 40kb up and downstream of TSSs for several genes in the 
Notch pathway.  For the seven genes from this set with NCEs or areas of enrichment 
(nrarpa, nrarpb, her4.2, her6, notch2, notch3, and hes5), we input sequences 750bp up 
and downstream of these loci into Clover.  The algorithm output consisted of binding 
sites for Suppressor of Hairless (Rbpsuh), a component of the Delta-Notch pathway (72), 
that were overrepresented with relation to combinations of H3K4me1, H3K4me3, and 
NCEs.  As a control, we compared this output to a set of FGF-responsive genes (erm, 
fgf3, fgfr1, fgf8, dusp6, spry1, spry4, and pea3) that also had H3K4me1 or H3K4me3 
enrichment within 40kb of their TSSs.  In addition, we analyzed the entire chromosome 
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15 as an additional control.  Finally, we performed the same analysis on our ChIP-Seq 
data for Notch and FGF genes by examining for overrepresentation of a large set of 
known transcription factor binding sites (including Rbpsuh).   
Similarly, we used the Multiple EM for Motif Elicitation (MEME) algorithm to 
look for overrepresented motifs (73).  This algorithm does not use known binding site 
sequences and, instead, simply examines motifs within unaligned DNA sequences.  
Output from this algorithm consists of a weighted sequence matrix.  For MEME analysis, 
we used the same sequences as with Clover.  Clover and MEME analyses were 
performed by Nathan Lawson. 
Enhancer cloning 
 To validate candidate enhancer elements, I used ChIP-Seq data from our whole 
embryo H3K4me1 dataset.  I considered the best candidates those with the most 
significant enrichment either within or shortly up or downstream of our selected target 
genes: her6, notch3, and dll4.  For her6 and notch3, I designed PCR primers to amplify a 
region ~500-750bp up and downstream of each peak (Table 2).  I used three peaks for  
 
her6 and two peaks for notch3.  The primers were designed with blunt-end restriction 
digest sites (SnaB1 or EcoRV, depending on the enhancer sequence) on each end.   
After amplifying genomic DNA using HotMaster Taq Polymerase (5Prime), I 
performed gel extraction and restriction digested the fragment ends.  I subsequently 
ligated each candidate enhancer upstream of an E1A basally active promoter in a 
Gene Peak Forward Primer (5’3’) Reverse Primer (5’3’) 
A GATCGATATCGAGAAAGAAACGCCAAGTCG CTAGCTATAGGCAGGGATATTGCAAATGGT 
B GATCGATATCTGCAACTCATCCTGTGGTGT CTAGCTATAGATCCTTGCGGGCTTTAACTT her6 
C GATCGATATCGCCAAAAGTTCAGGAGCAGA CTAGCTATAGGTTCGCCTCTTTCTCACGAC 
A GATCTACGTAGGCAGTAGTGCAATCCCAAA GATCTACGTACAGTGTGTGAAGTTGCAAAGG notch3 B GATCGATATCCCTGTTCATCCCAATTACACG CTAGCTATAGCACTGCTAAATTATTTTCTTTCCTTTG 
Table 2: Primers for her6 and notch3 Candidate Enhancer Amplification 
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Gateway entry clone and confirmed the sequence and 5’3’ orientation by PCR colony 
screen and direct sequencing.  I then performed a one hour LR reaction at room 
temperature (LR Clonase II, Invitrogen) to place this enhancer/promoter element 
upstream of the mCherry red fluorescent protein and an SV40 polyadenylation signal, 
thus creating a reporter construct to test enhancer function in vivo (64).  I confirmed 
successful reporter construct synthesis by restriction digest.   
 For dll4, I designed attB4 and attB1 Gateway primers flanking a region ~500-
750bp up and downstream of each peak (Table 3).  After PCR amplification, I performed 
a BP reaction (BP Clonase II, Invitrogen) for one hour at room temperature to recombine  
 
our candidate enhancers into a Gateway-compatible donor vector.  I confirmed the 
sequence and 5’3’ orientation by PCR colony screen and direct sequencing.  Next, I 
performed a one-hour LR reaction at room temperature to recombine this candidate 
enhancer into a Gateway expression clone upstream of the E1A promoter, EGFP, and 
SV40 polyadenylation signal.  I confirmed the expression clone sequence by restriction 
digestion.   
Injections 
 I injected reporter constructs along with Tol2 transposase mRNA into WT 
embryos at the one-cell stage, which permitted random incorporation into the zebrafish 
genome (74).  This was accomplished using a microinjection needle mounted to a three-
planar micromanipulator (World Precision Instruments) as previously described (75).  
Embryos were oriented in a Petri dish on 3% agarose medium for injections.  I injected 
Peak Forward Primer (5’3’) Reverse Primer (5’3’) 
A GGGGACAACTTTGTATAGAAAAGTTGAGTGCCAGGCCTCAATAATC GGGGACTGCTTTTTTGTACAAACTTGCCGCGTAGTGGTGGGTATTA 
B GGGGACAACTTTGTATAGAAAAGTTGGATTTGCGTTCGAGCTTACC GGGGACTGCTTTTTTGTACAAACTTGGTGCACGCTTTCAGTGATGT 
Table 3: Gateway-Compatible Primers for dll4 Candidate Enhancer Amplification 
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25 and 50pg of all constructs into ~100 embryos in duplicate using a PV 820 Pneumatic 
Pico Pump (World Precision Instruments).  At 24hpf, I added 0.003% 1-phenyl-2-
thiourea to prevent pigmentation.  I scored embryos for fluorescence from 24-48hpf.   
Immunostaining 
 Because fluorescence driven by these candidate enhancers can sometimes be 
difficult to detect visually, I also immunostained embryos following injection with 
antibodies specific to the respective fluorescent proteins.  Immunostaining was performed 
as previously described (65).  I used a rabbit anti-GFP antibody (Invitrogen) for detection 
of EGFP and a polyclonal anti-DsRed antibody (Living Colors, Clontech) for detection of 
mCherry. 
Microscopic imaging 
I scored embryos for immunofluorescence using a Leica MZFLIII Fluo Combi 
fluorescence stereomicroscope.  Nomarski imaging was performed using an Axioskop2 
Plus compound microscope (Zeiss), and images were captured using an AxioCam MRc 
digital camera (Zeiss).
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RESULTS 
 Because no previous studies have used ChIP-Seq to localize histone modifications 
in the zebrafish genome, we first needed to confirm such an approach was technically 
feasible.  Initially, we defined proper sonication conditions, as it is important to ensure 
consistent fragment length generation without excessive sonication, which increases the 
risk of DNA damage (76).  By sonicating chromatin derived from 24hpf WT whole 
embryos a total of five cycles, we were able to reproducibly obtain a distribution of 
chromatin ranging from 200-1,000bp (Fig. 2).  
Because the DNA was protein-bound, the true 
range of fragment size was less than that 
displayed on the agarose gel.  We found similar 
results using four rounds of sonication in our 
GFP+ and GFP- endothelial cell populations derived from Tg(fli1:egfp)y1 embryos (data 
not shown). 
 Following each ChIP experiment, we also performed several quality checks 
before ligating adapters for Genome Analyzer sequencing.  With ChIP experiments on 
WT embryos, we first determined the concentrations of each sample.  For these 
experiments, we found DNA enrichment for input and antibody samples ranging between 
2-4ng/µL, but the concentrations for negative controls lacking antibody precipitation 
were below the 2ng/µL threshold of detection for the Nanodrop (Table 4). 
In addition, we performed PCR analysis on each sample as another means of 
quality control.  Because both H3K4me1 and H3K4me3 localize to promoter regions of 
active genes (51), we used primers specific to the promoter regions of several genes 
 
Figure 2: Sonication adequately 
shears chromatin for subsequent 
immunoprecipitation.  Chromatin 
derived from 200 WT embryos at 
24hpf and sonicated for five minutes 
compared to 100bp ladder.  The 
majority of protein-bound fragments 
lie between 200-1,000bp. 
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expressed at 24hpf (data not shown).  For ChIP using anti-H3K4me3, we detected a 
strong gel band for input and antibody 
samples for both vascular and 
housekeeping genes (Fig. 3).  Bands for 
ChIP samples were slightly less intense.  
However, these corresponding sequences 
were nearly undetectable for our negative controls.  We found similar results with 
experiments using anti-H3K4me1 (data not shown). 
 We also wanted to determine if we could perform ChIP on endothelial cells 
isolated from transgenic zebrafish.  This presented a technical challenge because it would 
be difficult to isolate large numbers of cells from each clutch of embryos.  Thus, we first 
performed ChIP on various 
numbers of WT cells to 
determine the feasibility of 
such an approach.  Following 
ChIP, we subjected the 
remaining DNA to qPCR 
analysis.  Through this 
approach, we found significant enrichment of immunoprecipitated DNA for promoter 
regions of both fli1b and ef1α relative to samples with no added antibodies (Table 5).  
This was true for experiments using 5x105 and 1x106 cells with both anti-H3K4me1 and 
anti-H3K4me3 antibodies.  Because it would be easier to collect a smaller number of 
cells, we used 5x105 cells for subsequent experiments.   
Sample Concentration (ng/µL) 
Input 
No Antibody 
H3K4me1 
2.4 
1.8 
3.8 
Input 
No Antibody 
H3K4me3 
2.6 
1.8 
2.9 
Table 4: Spectrophotometry of Whole Embryo ChIP Samples 
 
Figure 3: ChIP can be used to purify DNA associated with specific modified 
histones in zebrafish embryos.  A – PCR performed on ChIP fragments isolated 
from 24hpf WT embryos using anti-H3K4me3.  Primers were specific to promoter 
regions of fli1b and aqp8, which are both expressed in the vasculature.  PCR 
amplified these sequences in both input and ChIP samples, but these sequences were 
nearly undetectable in negative controls.  B – PCR performed on the same samples 
using primers specific to promoter regions of two housekeeping genes, gapdh and 
ef1α.  Again, these sequences are present in the input and ChIP samples but not the 
negative controls. 
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 We performed ChIP and qPCR analysis on GFP+ and GFP- cells isolated from 
Tg(fli1:egfp)y1 embryos.  Because some evidence suggests H3K4me1 may be a better 
marker of enhancer elements (53; 
58; 59) and because the anti-
H3K4me3 antibody does not 
appear to be successful in ChIP 
with these small populations of 
cells (Table 5), we only used 
anti-H3K4me1 for these experiments.  As shown in Table 6, we again see strong 
enrichment of this histone modification in both GFP+ and GFP- cells using promoter-
specific primers for fli1b, aqp8, and ef1α. 
 Having confirmed that we could successfully perform ChIP on both whole 
zebrafish embryos as well as small populations of cells collected by FACS from 
transgenic embryos, we proceeded to prepare our samples for Illumina Genome Analyzer 
sequencing.  One crucial step in this process is PCR amplification of adapter-ligated 
fragments.  Although it is 
important that we have 
sufficient sample prior to 
deep sequencing, over-
amplification can result in 
artifactual overrepresentation of certain fragments (67).  Thus, we performed test PCR 
reactions with various cycles of amplification.  By doing this for each sample, we could 
determine the appropriate number of cycles necessary.  Figure 4 shows three different 
Number 
of Cells Antibody 
Fold 
Enrichment 
for fli1b 
(AB vs. no 
AB) 
Fold 
Enrichment 
for ef1α  
(AB vs. no 
AB) 
H3K4me1 45.20 18.83 1x106 H3K4me3 5.59 7.80 
H3K4me1 16.56 46.60 5x105 H3K4me3 N.D. N.D. 
Table 5: qPCR Analysis of Dissociated 24hpf WT Embryonic Cells 
 
Cells Antibody 
Fold 
Enrichment 
for fli1b (AB 
vs. no AB) 
Fold 
Enrichment 
for aqp8 (AB 
vs. no AB) 
Fold 
Enrichment 
for ef1α  (AB 
vs. no AB) 
5x105 
GFP+ H3K4me1 3.39 16.19 5.14 
  5x105    
   GFP- H3K4me1 5.02 8.30 5.56 
Table 6: qPCR Analysis of 24hpf Tg(fli1:egfp)y1 Endothelial Cells 
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24hpf WT samples derived from whole embryos.  In this case, eighteen rounds of 
amplification was the minimum number required 
for detection of a strong DNA smear for all 
samples.  We found similar results for experiments 
using endothelial cell isolates (data not shown).  
This method also allowed us to clearly visualize 
self-ligated adapters, which were represented by a 
band slightly smaller than 100bp (Fig. 4, arrow). 
 Once we confirmed that we could also successfully prepare our ChIP samples for 
deep sequencing, we sequenced our WT H3K4me1, H3K4me3, and input samples, which 
resulted in 11.9, 7.3, and 8.0 million uniquely mapping reads, respectively.  For our 
endothelial cell samples, we sequenced 6.6 million uniquely mapping H3K4me1 tags and 
7.4 million input tags.  Subsequently, we uploaded this data to the UCSC Genome 
Browser for visualization.  Figure 5 shows the distribution of both H3K4me1 and 
H3K4me3 enrichment in 24hpf WT whole embryos near notch3.  In this case, we see five 
 
Figure 4: Few rounds of PCR amplification are 
needed for ChIP-Seq.  Adapter-ligated ChIP-seq 
fragments from 24hpf WT whole embryos.  Each 
sample was amplified for 15, 18, and 20 rounds, and 
10% was analyzed by gel electrophoresis after each 
of these series.  In this case, 18 rounds of PCR 
amplification provided adequate DNA for deep 
sequencing.  Also, there was sufficient resolution 
between sample and self-ligated adapters (arrow). 
 
Figure 5: ChIP-Seq identifies regions of H3K4me1 and H3K4me3 enrichment that also correspond to 
NCEs and protein binding sites.  ChIP-seq on 24hpf WT whole embryos with anti-H3K4me1 and anti-
H3K4me3.  Data for notch3, which is expressed by arterial endothelial cells as well as the CNS, is displayed in 
the UCSC Genome Browser.  There are five regions (blue arrows) of H3K4me1 enrichment.  Of note, four of 
the regions (blue shading) correspond to NCEs highly conserved in vertebrates, while one region (yellow 
shading) corresponds to both an NCE and an Rbpsuh binding site.  We also observe strong enrichment of 
H3K4me3 (red arrow) at a region corresponding to both the TSS of notch3 as well as an Rbpsuh binding site 
(red shading). 
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regions of H3K4me1 enrichment (Fig. 5, blue arrows) both upstream and within the 
gene sequence.  In all cases, these regions also correspond to NCEs (Fig. 5, blue 
shading), and one region also maps to an Rbpsuh binding site (Fig. 5, yellow shading).  
We also see enrichment of H3K4me3 at both the promoter region as well as an Rbpsuh 
binding site (Fig. 5, red arrow and red shading).   
 We compiled our ChIP-Seq data to determine the distribution of H3K4me1 and 
H3K4me3 around TSSs (Fig. 6).  For H3K4me3, we see high amplitude enrichment at 
the TSS with the majority of 
this enrichment slightly skewed 
upstream (Fig. 6A).  This peak 
of enrichment falls sharply up 
and downstream of the TSS.  
With H3K4me1, we again see 
enrichment at the TSS, 
although this peak is broader 
and much lower in amplitude (Fig. 6B).  Furthermore, we see low amplitude enrichment 
within 10kb up and downstream of the TSS, although this enrichment is greater in 
amplitude upstream. 
Next, we examined all genes in the zebrafish genome and characterized the 
presence of H3K4me1 and H3K4me3 peaks and well as NCEs +/- 350bp of their TSSs 
(Table 7).  Although the vast majority of genes exhibited no epigenetic enrichment near 
their TSSs, we found ~2,500 H3K4me1 and ~7,100 H3K4me3 peaks in these regions.  
 
Figure 6: ChIP-Seq characterizes unique distributions of H3K4me3 and 
H3K4me1 around TSSs in the zebrafish genome.  ChIP-Seq on 24hpf WT 
whole embryos.  A – Graph A shows the correlation between H3K4me3 peaks and 
TSSs.  These peaks cluster at the TSS with very few peaks up or downstream.  B – 
Graph B shows the correlation between H3K4me1 and TSSs.  Note the much 
smaller amplitude of enrichment at the TSS compared to H3K4me3.  Also, the 
enrichment up and downstream of the TSS does not taper as drastically as that of 
H3K4me3. 
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Approximately 1,800 TSSs were marked by both H3K4me1 and H3K4me3, and we 
found several hundred regions of epigenetic enrichment that also corresponded to NCEs.   
  
 
 
  
  
 We subsequently broadened our analysis to include all regions of the genome, not 
just TSSs (Table 8).  By doing so, we identified nearly ten times more regions of 
H3K4me1 enrichment compared to H3K4me3.  There are ~11,500 regions with both, of 
which we already 
determined ~1,800 are 
located near the TSS 
(Table 7).  Similarly, 
whereas only a few hundred regions with epigenetic marks in addition to NCEs were 
located near TSSs (Table 7), we identified several thousand more within the whole 
genome (Table 8).  
 Using the Clover algorithm, we scanned regions corresponding to NCEs as well 
as H3K4me1 and H3K4me3 enrichment near genes within the Notch signaling pathway 
for overrepresentation of Rbpsuh binding sites.  Within this pathway, we identified seven 
genes characterized by flanking sequences containing both enrichment for an NCE or a  
specific histone modification as well as a statistically significant overrepresentation of 
Rbpsuh binding sites (Table 9).  Of note, the majority of these Rbpsuh binding sites did 
not map to NCEs.  When the same analysis was performed using genes within the FGF 
 No Peaks 
H3K4me1 
Peak 
H3K4me3 
Peak NCE 
me1 + 
me3 
Peaks 
me1 
Peak 
+ 
NCE 
me3 
Peak 
+ 
NCE 
me1 
+ 
me3 
+ 
NCE 
   Number of    
   Genes with 
Corresponding    
     Features 
16,056 2,514 7,106 2,250 1,779 320 806 211 
Table 7: Characterization of Regions +/- 350bp of TSSs in 24hpf WT Embryos 
 
 H3K4me1 Peak 
H3K4me3 
Peak 
me1 + 
me3 
me1 + 
NCE 
me3 + 
NCE 
me1 + 
me3 + 
NCE 
   Number of    
  Regions with 
Corresponding   
     Elements 
227,742 22,450 11,483 11,465 7,893 4,275 
Table 8: Epigenetic Characterization of the Entire WT Genome at 24hpf 
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pathway, there was no detectable overrepresentation of Rbpsuh binding sites (data not 
shown).  Finally, when the Notch gene set was again analyzed by Clover for a large set of 
transcription 
factor binding 
motifs instead 
of Rbpsuh 
alone, the 
algorithm again identified sites of Rbpsuh enrichment (data not shown).  Using MEME, 
we analyzed these same flanking regions for motif-overrepresentation (Fig. 7).  This 
analysis revealed an 
overrepresented motif in 
the flanking regions near 
her4.2, her6, nrarpa, and 
notch3 (Fig. 7B) very 
similar to the Rbpsuh consensus binding sequence (Fig. 7A).  Again, the majority of 
these cis-elements associated with Rbpsuh binding sites did not correspond with NCEs. 
We also compared our ChIP-Seq data to a set of known enhancers.  A previous 
study identified several functional cis-elements near the fgf8a locus in zebrafish (38).  
Using the UCSC Genome Browser, we found that many of these confirmed enhancers are 
closely associated with areas of significant H3K4me1 enrichment (Fig. 8, blue boxes).  
Interestingly, all six of these regions lie downstream of fgf8a. 
Gene H3K4me1 + Rbpsuh 
H3K4me3 
+ Rbpsuh 
NCE + 
Rbpsuh 
me1 + 
me3 + 
Rbpsuh 
me1 + 
NCE + 
Rbpsuh 
me3 + 
NCE + 
Rbpsuh 
me1 + 
me3 + 
NCE + 
Rbpsuh 
nrarpa — 1 1 2 — — — 
nrarpb — 4 — — 1 — — 
her4.2 4 — 2 2 — — — 
her6 — — 2 1 — — — 
hes5 — — 1 — — — — 
notch2 2 — — — — — — 
notch3 — 1 2 — 1 — — 
Table 9: Frequency of overrepresented Rbpsuh binding sites near Notch signaling gene set and 
relation to epigenetic modifications and evolutionary conservation, p<0.001 
 
 
Figure 7: MEME analysis reveals overrepresentation of Rbpsuh consensus sequences.  
A – Logo of mouse Rbpsuh binding site.  B – Putative cis-elements containing Rbpsuh 
binding sites identified using MEME algorithm. 
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Figure 8: H3K4me1 is enriched at sites of known zebrafish enhancers.  By comparing ChIP-Seq data from H3K4me1 in 
whole embryos to a dataset of confirmed zebrafish enhancers near fgf8a, we found six regions (blue boxes) of overlap. 
 
Figure 9: ChIP-Seq on an endothelial cell population reveals unique regions of epigenetic modifications.  We 
compared H3K4me1 modifications from an endothelial cell population to the whole embryo at 24hpf.  A – For the 
region surrounding flt4, the endothelial population was markedly enriched for H3K4me1 within the first intron (blue 
box).  This enrichment was absent from the whole embryo analysis.  B – For the region surrounding kdrl, the endothelial 
population lacked four regions of significant H3K4me1 enrichment seen in whole embryo analysis (blue boxes). 
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Next, we compared our H3K4me1 ChIP-Seq data from both whole embryos and 
Tg(fli1:egfp)y1 GFP+ cells (Fig. 9).  For flt4 (VEGFR3), whole embryo analysis initially 
revealed no areas of significant H3K4me1 enrichment.  By contrast, endothelial cells 
exhibited marked enrichment for this modification within the first intron of flt4 (Fig. 9A, 
blue box).  On the other hand, analysis of kdrl in whole embryos initially showed four 
regions of significant H3K4me1 enrichment.  The endothelial cell population, however, 
exhibited no such enrichment (Fig. 9B, blue boxes). 
Finally, we used our H3K4me1 ChIP-Seq data to identify candidate enhancers 
and validate their function in vivo using a reporter construct.  For this analysis, we used 
our WT rather than our endothelial cell data because we had performed deeper 
sequencing on the former.  Also, this dataset permitted us to include H3K4me3 
enrichment.  By using Gateway 
recombination-based technology, we 
cloned our candidate enhancers into 
expression clones driving expression 
of either mCherry or GFP (Fig. 10).  
We initially chose seven candidate 
enhancers, three for her6 and two 
each for notch3 and dll4.  One such 
~1200bp candidate for notch3 lay upstream of the TSS.  It was characterized by 
H3K4me1 enrichment and mapped to an NCE as well as an Rbpsuh binding site (Fig. 
11A, blue box).  After injecting this construct into embryos and assaying at ~28hpf, we 
found expression in the notochord (Fig. 11C, arrow) as well as the floor plate of the 
 
Figure 10: Gateway technology permits rapid synthesis of in vivo 
expression clones for enhancer validation.  By using Gateway 
recombination-based technology, we were able to quickly clone putative 
enhancers upstream of a basal promoter driving the expression of a 
fluorescent protein, in this case mCherry.  This construct also contains 
transposable elements for incorporation into the zebrafish genome.  We 
injected these constructs into 1-cell WT zebrafish embryos and 
examined for expression of fluorescence at 24-48hpf. 
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neural tube (Fig. 11C, arrowheads).  This corresponds to early Notch activation in these 
same regions in a Notch-indicator transgenic zebrafish line (data not shown).  Another 
candidate lay downstream of her6 and mapped to a region of both H3K4me1 and 
H3K4me3 enrichment (Fig. 11B).  This 1200bp region also corresponded to two Rbpsuh 
binding sites (Fig. 11B, blue box).  At ~28hpf, this enhancer drove expression of 
mCherry in the fin fold (Fig. 11D, arrowhead) as well as in tissue posterior to the eye 
(Fig. 11E, arrows).  The other 5 candidates yielded no appreciable expression. 
Therefore, in total, we were able to validate 2/7 candidate enhancers.  
 
 
 
 
 
 
Figure 11: Enrichment of modified histones identifies functional enhancers.  A – One candidate enhancer corresponds to 
a region of H3K4me1 enrichment upstream of the notch3 TSS.  This ~1200bp region (boxed) also maps to an NCE and an 
Rbpsuh binding site.  B – The other candidate enhancer localizes to a region of both H3K4me1 and H3K4me3 enrichment 
downstream of her6, which is a Notch signaling target gene widely expressed in the CNS.  This ~1200bp region (boxed) also 
contains two Rbpsuh binding sites.  C, D, & E – After injecting our enhancer constructs, embryos were fixed at 28hpf and 
immunostained with a dsRed antibody, which amplified the fluorescent signal.  C – Our notch3 candidate enhancer yielded 
expression in the notochord (arrowheads) as well as the floor plate of the neural tube (arrow) in the tail.  This corresponds to 
Notch activation in zebrafish embryos in both the notochord and neural tube.  D & E – With our her6 candidate enhancer, we 
see expression in the fin fold (arrowhead) and in tissue posterior to the eye (arrows). 
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CONCLUSIONS 
 Few studies have used ChIP-Seq to study modified histones in vertebrates.  Thus, 
we faced a technical hurdle in developing a viable ChIP-Seq protocol for whole embryos 
as well as extremely small cell populations.  Some studies have used micrococcal 
nuclease digestion instead of sonication for chromatin shearing (51).  There is even some 
evidence that micrococcal digestion yields a better signal to noise ratio than sonication 
(77).  However, some studies using micrococcal nuclease (51) digest the chromatin prior 
to crosslinking, which may permit rearrangement of the nucleosomes during the 
endonuclease treatment (78).  As shown in Figure 2, we found sonication to be an ideal 
means of quickly, cheaply, and reproducibly shearing chromatin into an appropriate size 
range.  Other large centers also utilize mechanoacoustic methods of chromatin shearing 
in their standard protocols (46).   
 Given the expense and time required for next generation sequencing, it was 
critical that we confirm success of our ChIPs before proceeding.  The concentrations 
displayed in Table 4 indicate that we were successful in precipitating DNA fragments 
from whole embryos.  Both our samples treated with antibody and our input samples 
were detectable by spectrophotometry, but our negative controls were not.  Although the 
values were not drastically different, we consistently observed similar results for samples 
that successfully underwent subsequent deep sequencing, and our confidence in initially 
using spectrophotometry analysis was confirmed by the results in Figure 3.  Because 
previous evidence indicated both H3K4me1 and H3K4me3 were enriched at promoter 
regions (51), we used promoter-specific primers for this PCR analysis.  Amplification 
yielded strong gel bands for our ChIP and input samples.  We expect input samples to 
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still contain these sequences, which the electrophoresis confirmed.  Bands were nearly 
undetectable for our negative controls, thus confirming success of the ChIPs.  Although 
this method is less precise than qPCR, the differences in band intensity were striking, and 
standard PCR requires less chromatin and is also less expensive. 
 For ChIP on small populations of cells, we determined effectiveness using qPCR, 
as the chromatin yield was much lower than with whole embryos.  As shown in Table 5, 
we were able to successfully perform ChIP with 5x105 cells.  This is a significant feat, as 
many other ChIP experiments require as many as 5x107 cells (48).  Also, because we 
could use such a small number of cells, we were able to collect fewer clutches of 
embryos for our subsequent ChIP experiments.  Of note, the enrichment for anti-
H3K4me1 was much stronger than anti-H3K4me3, indicating this antibody was more 
effective with a smaller pool of epitopes.  We next turned to ChIP on endothelial cells 
isolated by FACS from Tg(fli1:egfp)y1 embryos, and we compared enrichment of 
H3K4me1 (but not H3K4me3) at promoter regions from both GFP+ endothelial cells and 
GFP- cells (Table 6).  Enrichment at the promoter of ef1α, a housekeeping gene, was 
nearly identical in both populations.  This was expected, since nearly all cells should be 
utilizing this gene and controlling its associated epigenetic marks in similar ways.  
However, we saw differences for fli1b and aqp8, indicating that these different cell 
populations control epigenetic marks at these loci differently. 
 Another major concern was avoiding overamplification of our adapter-ligated 
library, as this would increase the likelihood of PCR artifacts (67).  As shown in Figure 
4, we performed several trial runs of PCR amplification.  In examining the gel, we looked 
for the minimum number of PCR cycles that yielded an easily detectable smear of 
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fragments, in this case 18 cycles.  Using gel electrophoresis also allowed us to visualize 
self-ligated adapters and eliminate them during gel extraction.  One must take care to 
avoid these sequences, because they will otherwise be included in cluster amplification 
and deep sequencing (46). 
 After compiling our ChIP-Seq data, we used the UCSC genome browser to 
explore the distribution of modified histone enrichment near genes of interests.  In Figure 
5, one can see how closely H3K4me1 enrichment corresponds to NCEs and Rbpsuh 
binding sites near notch3, and this occurs both upstream of the TSS and within introns.  
Also, H3K4me3 is enriched at the TSS.  Although this visual snapshot only highlights 
one gene, it clearly shows the wealth of information such analysis can provide. 
 In order to understand our ChIP-Seq findings throughout the genome, we 
compiled distribution maps for H3K4me1 and H3K4me3 enrichment relative to all TSSs 
(Fig. 6).  Consistent with other studies (51-53), we found H3K4me3 to be sharply 
enriched near TSSs.  As in other studies (51), H3K4me1 is also enriched at TSSs, 
although not to as great a degree.  We also see lower level H3K4me1 enrichment up and 
downstream of TSSs, which may represent an association between this mark and cis-
elements, which other studies have also found (51; 53; 58; 59).  Next, we further 
characterized TSS flanking regions (Table 7) and found that the majority lacked 
H3K4me1 and H3K4me3 enrichment.  This finding suggests these marks are not widely 
distributed around promoter regions, and cells are tightly controlling their placement.  
There are many more instances of H3K4me3 enrichment associated with these sequences 
than H3K4me1.  Interestingly, we found 211 regions characterized by both H3K4me1 
and H3K4me3 enrichment as well as evolutionary conservation.  Such a high degree of 
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epigenetic regulation in these highly conserved areas may indicate these sequences are 
particularly important in the organism. 
 We expanded this same analysis to include the entire genome instead of just 
regions surrounding TSSs (Table 8).  By doing so, we located 10-fold more regions of 
H3K4me1 enrichment versus H3K4me3, which supports previous findings of H3K4me1 
enrichment primarily at cis-elements (51; 53; 58; 59).  Again, we found more than 4,000 
highly conserved regions of H3K4me1 and H3K4me3 enrichment.  Such regions may 
represent cis-elements with more significant or widespread roles than those marked by 
only one type of modified histone. 
 In order to determine if our ChIP-Seq data was able to locate known transcription 
binding sites, we used the Clover algorithm to examine genes in the Notch pathway 
(Table 9).  Upon Notch activation, Rbpsuh functions with other proteins to drive target 
gene expression (79).  Therefore, we would expect this Notch gene dataset to contain 
Rbpsuh binding sites, and these sites should correspond to epigenetic modification.  
Clover found Rbpsuh binding sites enriched for various combinations of modified 
histones near five of the Notch genes examined, which indicates the power of our 
experimental approach in identifying cis-elements.  The majority of these sites were not 
associated with NCEs, suggesting histone modification is a better predictor of cis-
elements.  When we performed the same analysis on genes in the FGF pathway, Clover 
did not identify any Rbpsuh sites, which is what we expected since that protein does not 
have a known role in FGF signaling.  Additionally, we searched for multiple transcription 
factor binding sites using this same analysis on both Notch and FGF genes.  We included 
this analysis as a way to avoid biasing toward Rbpsuh.  In this case, we again found 
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regions of modified histone enrichment mapping to Rbpsuh binding sites in the Notch 
gene set but not with FGF, further supporting our findings.  Similarly, we subjected these 
same sequences to MEME analysis (Fig. 7), which also identified several regions that 
closely resembled Rbpsuh binding sites. 
 Despite the results of our Clover and MEME analyses, an association between 
histone modifications and transcription factor binding sites does not necessarily indicate 
proteins actually occupy these sites (26).  Therefore, we compared our data to a set of 
known enhancers (Fig. 8).  We found six regions of H3K4me1 enrichment corresponding 
to known enhancers for fgf8a, indicating our ChIP-Seq approach is successful at 
identifying functional enhancer elements.  Although other known enhancers from this 
dataset are not marked by enrichment, it is possible that deeper sequencing of our sample 
may yield enrichment at these areas. 
 Since we are primarily interested in vascular development, we wanted to 
determine if epigenetic marks from endothelial cells alone would provide more pertinent 
information than ChIP-Seq on whole embryos.  To do this, we performed ChIP-Seq on 
endothelial cells harvested from Tg(fli1:egfp)y1 embryos and compared the results to our 
whole embryo analysis (Fig. 9).  In some cases, the endothelial cells exhibited H3K4me1 
enrichment that was absent in whole embryos (Fig. 9A).  This may occur because the 
signal is only present in a small population of cells and is diluted in whole embryo 
samples.  In other cases, enrichment present in whole embryos was absent from 
endothelial cells (Fig. 9B).  Sequences at these loci may not be functioning as promoters 
or cis-elements in the endothelial cell population.  Using endothelial-specific epigenetic 
profiles may be a more reliable approach for identifying candidate cis-elements, and in 
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the future, we plan to perform deeper sequencing of these samples in order to obtain more 
sequence tags and increase our ability to accurately predict cis-elements functioning in 
the zebrafish vasculature. 
 Several previous studies examining the relationship between modified histones 
and enhancers relied exclusively on predicted rather than functional enhancers (51; 53; 
58; 59).  Those that do functionally validate predicted enhancers rely upon ChIP-Seq data 
using enhancer binding proteins or CNEs, not epigenetic modification (37; 60).  We felt 
functionally validating candidate enhancers identified from our ChIP-Seq data was 
essential, and our approach using modified histones represented a more global survey 
than one relying on known enhancer binding proteins.  Using H3K4me1 enrichment, we 
assayed seven candidate enhancers near three genes in the Notch pathway: her6, notch3, 
and dll4 (Fig. 11).  Although these genes are expressed in the vasculature (data not 
shown), the candidate enhancers drove reporter gene expression elsewhere.  One notch3 
enhancer drove expression in the notochord and neural tube (Fig. 11C), while a her6 
enhancer drove expression in the fin fold (Fig. 11D) and in tissue posterior to the eye 
(Fig. 11E).  It is possible these enhancers normally function to facilitate expression of 
distant genes instead of those in close proximity, as enhancers are known to function at 
distances of up to one megabase (33).  Of the seven candidates tested, we were only able 
to validate two.  Previous studies using CNEs and P300 binding to predict enhancers 
yielded much higher success rates (37; 60).  Our success rate may improve if we tested 
more candidates and examined for expression at different timepoints.  Also, using regions 
of H3K4me1 enrichment specifically from our endothelial cell dataset may prove a better 
means of identifying enhancers for vascular gene expression.  In addition, it is possible 
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some of these candidates are in fact insulators or repressors.  H3K4me1 is associated with 
insulator elements (51), and there are also instances of long-range repression via cis-
elements in zebrafish and other organisms (32; 80).  We plan to design constructs to test 
for insulator and repressor function, and results from these experiments may reveal an 
additional use of our dataset for predicting cis-elements. 
By using ChIP-Seq technology, we have created the first map of H3K4me1 and 
H3K4me3 enrichment in WT zebrafish embryos as well as endothelial cells collected 
from transgenic zebrafish.  In addition, we have characterized the relation of these 
epigenetic marks to each other as well as CNEs and TSSs.  Predicted enhancers from our 
data map to transcription factor binding sites as well as to confirmed zebrafish enhancers.  
Finally, we ourselves functionally assayed several predicted enhancers and confirmed 
their ability to drive target gene expression.  We believe our approach represents a more 
thorough method of predicting and screening candidate cis-regulatory elements in the 
zebrafish genome.  Our method avoids the limited scope of experiments using known 
enhancer-binding proteins, and it is less speculative than those relying simply on 
predicted protein binding sites or evolutionary conservation.  Through further analysis, 
our data may also reveal a role in predicting insulator and repressor elements.  By making 
our data publicly available, we will have created an invaluable resource for numerous 
researchers.  Also, it will permit us to further explore the roles of specific cis-regulatory 
elements in vascular development as well as the role of modified histones in embryonic 
development.  This is part of a new wave of research focusing on epigenetics and 
technology that permits genome-wide analyses, and it represents a powerful tool for 
ultimately studying human disease. 
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